Clinical Trials › NCT06592352
RecruitingPhase 2
MODAFIMS: A Trial to Evaluate Predictors of Response to MODAFinil in Patients With Multiple Sclerosis
Sponsored by Clinical Academic Center (2CA-Braga)
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 64
Target enrollment
Aug 2024
Start date
Sep 2026
Expected completion
Interventions / Treatments
Modafinil Generis 100 mg
Conditions studied
Multiple Sclerosis
Trial locations
U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.
